TrialCancer chemotherapy and pharmacology2021

Phase II study of trifluridine/tipiracil (TAS-102) therapy in elderly patients with colorectal cancer (T-CORE1401): geriatric assessment tools and plasma drug concentrations as possible predictive biomarkers.

Masanobu Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.